Pyridoxine compared to other semaglutide compound additives Pyridoxine is not the only additive used in compounded semaglutide
The cardiometabolic improvements seen during semaglutide treatment reverted towards the baseline in our study, similar to the findings in the STEP 1 study ( When interpreting the endocrine and cardiometabolic outcomes, it is important to highlight that participants in our cohort were already treated with metformin before the semaglutide intervention, therefore prior the baseline assessment
Moore SA, Hrisos N, Errington L, Rochester L, Rodgers H, Witham M, et al
The same module found a 20% increase in metoprolol Cmax (unchanged AUC), also deemed not clinically significant [1]
If an LMN is appropriate, an independent licensed practitioner (via Truemeds clinical partner) will review your medical history, and if you qualify, theyll issue the LMN
GLP-1 receptor agonists are a class of medications initially developed to treat type 2 diabetes